Anti-Rh(D) Immunoglobulin Injection from Japan
A blood fraction containing antibodies against Rh(D) antigen, administered prophylactically to prevent hemolytic disease in newborns. Classified in HTS 3002.12.0090 as an antiserum derived from human plasma via biotechnological processes for therapeutic use. It targets specific immunological responses rather than general blood components.
Duty Rate — Japan → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Include lot-specific Rh antibody titer reports and sterility certificates to comply with biologics import regs
• Use validated shipping containers for temperature control; declare as pharmaceutical to avoid inspection delays